• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监狱中异烟肼预防治疗:系统评价。

Isoniazid preventive therapy in correctional facilities: a systematic review.

机构信息

Centre of Excellence for Research in AIDS, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

Int J Tuberc Lung Dis. 2012 Jul;16(7):871-9. doi: 10.5588/ijtld.11.0447. Epub 2012 Mar 7.

DOI:10.5588/ijtld.11.0447
PMID:22410101
Abstract

Tuberculosis (TB) remains a major cause of morbidity and mortality worldwide and the main cause of death in correctional facilities in middle- and low-income countries. Due to the closed environment and the concentration of individuals with TB-related risk factors, effective measures are required to control TB in such settings. Isoniazid preventive therapy (IPT) represents an effective and cost-effective measure. Despite international recommendations that IPT be integral to TB control, it is seldom deployed. A systematic review of interventions used to assess IPT initiation and completion in correctional facilities was conducted using published studies from two biomedical databases and relevant keywords. Additional references were reviewed, resulting in 18 eligible studies. Most (72%) studies were conducted in the United States and in jail settings (60%), with the main objective of improving completion rates inside the facility or after release. Studies that provided data about initiation and completion rates showed poor success in correctional facilities. Adverse consequences and treatment interruption ranged from 1% to 55% (median 5%) in reported studies; hepatotoxicity was the most prevalent adverse reaction. Despite its accelerating effect on the development of active TB, information on human immunodeficiency virus (HIV) status was provided in only half of the studies. Among the four studies where IPT effectiveness was assessed, the results mirror those described in community settings. Future studies require thorough assessments of IPT initiation and completion rates and adverse effects, particularly in low- and middle-income countries and where comorbid viral hepatitis may contribute significantly to outcomes, and in settings where TB and HIV are more endemic.

摘要

结核病(TB)仍然是全球发病率和死亡率的主要原因,也是中低收入国家惩教设施中主要的死亡原因。由于封闭的环境和聚集了具有与结核病相关的风险因素的个体,因此需要采取有效的措施来控制这些环境中的结核病。异烟肼预防治疗(IPT)是一种有效且具有成本效益的措施。尽管国际建议将 IPT 作为结核病控制的重要组成部分,但很少在实践中采用。使用发表在两个生物医学数据库和相关关键词中的研究,对评估惩教设施中 IPT 起始和完成情况的干预措施进行了系统综述。对额外的参考文献进行了审查,最终有 18 项符合条件的研究。大多数(72%)研究在美国和监狱环境中进行(60%),主要目的是提高设施内或释放后的完成率。提供了起始和完成率数据的研究表明,在惩教设施中成功率较低。不良后果和治疗中断率在报告的研究中从 1%到 55%(中位数为 5%)不等;肝毒性是最常见的不良反应。尽管 IPT 对活动性结核病的发展有加速作用,但只有一半的研究提供了关于人类免疫缺陷病毒(HIV)状况的信息。在评估 IPT 有效性的四项研究中,结果与社区环境中描述的结果相似。未来的研究需要对 IPT 的起始和完成率以及不良反应进行全面评估,特别是在中低收入国家以及病毒性肝炎可能对结果有重大影响的国家,以及结核病和 HIV 更为流行的国家。

相似文献

1
Isoniazid preventive therapy in correctional facilities: a systematic review.监狱中异烟肼预防治疗:系统评价。
Int J Tuberc Lung Dis. 2012 Jul;16(7):871-9. doi: 10.5588/ijtld.11.0447. Epub 2012 Mar 7.
2
Treatment of latent tuberculosis infection in HIV infected persons.HIV感染者潜伏性结核感染的治疗。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD000171. doi: 10.1002/14651858.CD000171.pub3.
3
Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts.异烟肼预防治疗在预防埃塞俄比亚艾滋病毒感染者结核病中的应用:一项实施情况和影响的系统评价。
Int J Environ Res Public Health. 2022 Dec 29;20(1):621. doi: 10.3390/ijerph20010621.
4
Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.结核病预防性治疗对感染艾滋病毒儿童的结核病及死亡率的影响。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD006418. doi: 10.1002/14651858.CD006418.pub2.
5
Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.资源匮乏环境下 HIV 感染者结核菌素皮肤试验反应的系统评价:异烟肼预防治疗的意义。
PLoS One. 2012;7(11):e49928. doi: 10.1371/journal.pone.0049928. Epub 2012 Nov 27.
6
Treatment of latent tuberculosis infection in HIV infected persons.HIV感染者潜伏性结核感染的治疗。
Cochrane Database Syst Rev. 2004(1):CD000171. doi: 10.1002/14651858.CD000171.pub2.
7
Isoniazid for preventing tuberculosis in HIV-infected children.异烟肼用于预防感染艾滋病毒儿童的结核病。
Cochrane Database Syst Rev. 2017 Aug 29;8(8):CD006418. doi: 10.1002/14651858.CD006418.pub3.
8
Six-month therapy for abdominal tuberculosis.腹部结核的六个月治疗
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD012163. doi: 10.1002/14651858.CD012163.pub2.
9
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.基于人群的生物医学性传播感染控制干预措施以减少艾滋病毒感染。
Cochrane Database Syst Rev. 2011 Mar 16(3):CD001220. doi: 10.1002/14651858.CD001220.pub3.
10
Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis.在非洲感染 HIV 的个体中进行强化病例发现和异烟肼预防治疗:经济模型和信息价值分析。
PLoS One. 2012;7(1):e30457. doi: 10.1371/journal.pone.0030457. Epub 2012 Jan 23.

引用本文的文献

1
Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment.在全球结核病预防性治疗指南中优先考虑被剥夺自由的人。
PLoS Med. 2023 Oct 3;20(10):e1004288. doi: 10.1371/journal.pmed.1004288. eCollection 2023 Oct.
2
Protocol for pragmatic randomized clinical trial to evaluate the completion of treatment of latent Mycobacterium tuberculosis infection with Isoniazid in the 300 mg formulation.评价 300 毫克规格异烟肼治疗潜伏性结核分枝杆菌感染治疗完成情况的实用型随机临床试验方案。
PLoS One. 2023 Feb 21;18(2):e0281638. doi: 10.1371/journal.pone.0281638. eCollection 2023.
3
Delivery of TB preventive therapy to incarcerated people living with HIV in southern African correctional facilities.
在南部非洲惩教设施中,向感染艾滋病毒的在押人员提供结核病预防治疗。
Public Health Action. 2021 Dec 21;11(4):171-173. doi: 10.5588/pha.21.0056.
4
Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study.泰国囚犯中潜伏性结核感染的患病率及结核病预防性治疗的可行性:一项横断面研究。
BMC Public Health. 2021 Jun 24;21(1):1206. doi: 10.1186/s12889-021-11271-0.
5
Prevalence of latent tuberculosis infection and associated risk factors in prison in East Wollega Zone of western Ethiopia.埃塞俄比亚西部东沃洛格地区监狱中潜伏性结核感染的流行状况及其相关危险因素。
PLoS One. 2020 May 19;15(5):e0233314. doi: 10.1371/journal.pone.0233314. eCollection 2020.
6
Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.坦桑尼亚达累斯萨拉姆地区 2013 年至 2017 年间,接受护理和治疗诊所服务的艾滋病毒感染者中异烟肼预防性治疗完成情况的决定因素。一项横断面分析研究。
BMC Infect Dis. 2020 Apr 10;20(1):276. doi: 10.1186/s12879-020-04997-6.
7
Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews.低结核病发病率国家减少结核病发病率干预措施的效果:系统评价综述。
Eur Respir Rev. 2019 May 29;28(152). doi: 10.1183/16000617.0107-2018. Print 2019 Jun 30.
8
Coordinating the prevention, treatment, and care continuum for HIV-associated tuberculosis in prisons: a health systems strengthening approach.协调监狱中艾滋病毒相关结核病的预防、治疗和护理连续体:一种加强卫生系统的方法。
Curr Opin HIV AIDS. 2018 Nov;13(6):492-500. doi: 10.1097/COH.0000000000000505.
9
A situational analysis of latent tuberculosis infection among incarcerated population in Japan.日本被监禁人群中潜伏性结核感染的情境分析。
PLoS One. 2018 Sep 7;13(9):e0203815. doi: 10.1371/journal.pone.0203815. eCollection 2018.
10
High Completion Rate for 12 Weekly Doses of Isoniazid and Rifapentine as Treatment for Latent Mycobacterium tuberculosis Infection in the Federal Bureau of Prisons.在联邦监狱管理局,12周剂量的异烟肼和利福喷丁作为潜伏性结核分枝杆菌感染治疗方案的完成率很高。
J Public Health Manag Pract. 2019 Mar/Apr;25(2):E1-E6. doi: 10.1097/PHH.0000000000000822.